Results 131 to 140 of about 596,809 (161)

Metronidazole with Lactacyd vaginal gel in bacterial vaginosis

Journal of Obstetrics and Gynaecology Research, 2006
AbstractAim:  To assess the efficacy and tolerability of lactic acid (Lactacyd vaginal gel; LVG) when given as an adjunct to metronidazole in the treatment of bacterial vaginosis (BV) among Filipino patients.Methods:  A multicenter, open‐labeled, controlled, randomized, three‐arm comparative study on 90 women aged 18 years or over with clinically and ...
Ditas Cristina D, Decena, Jennifer T, Co, Ricardo M, Manalastas, Evelyn P, Palaypayon, Christia S, Padolina, Judith M, Sison, Louella A, Dancel, Marievi A, Lelis   +7 more
exaly   +3 more sources

A comparative study of the therapeutic effects of the Zataria multiflora vaginal cream and metronidazole vaginal gel on bacterial vaginosis

Phytomedicine, 2008
Bacterial vaginosis (BV) is one of most prevalent complications among reproductive-aged women. Metromidazole prescription, which is considered as the first-line treatment of BV, is usually followed by a few side effects. Besides, there is a growing tendency toward herbal medicines for the treatment of vaginitis.
Zohreh Azarbad, Masoumeh Simbar
exaly   +3 more sources

A Pilot Study of Metronidazole Vaginal Gel Versus Oral Metronidazole for the Treatment of Trichomonas vaginalis Vaginitis

Sexually Transmitted Diseases, 1998
Trichomonas vaginalis is a common sexually transmitted pathogen. In the United States, oral metronidazole is the only officially sanctioned treatment option.This study was undertaken to compare the efficacy and safety of 0.75% metronidazole vaginal gel with that of oral metronidazole for the treatment of trichomonal vaginitis.Women with trichomoniasis ...
James A McGregor, William M McCormack, J A McGregor   +2 more
exaly   +3 more sources

Thrombotic Thrombocytopenic Purpura Induced by Metronidazole Vaginal Gel

Pharmacotherapy, 2007
Thrombotic thrombocytopenic purpura (TTP) is a rare, life‐threatening disorder characterized by microangiopathic hemolytic anemia and thrombocytopenia. Patients with TTP often have an increased reticulocyte count, elevated serum lactate dehydrogenase level, and decreased serum haptoglobin level.
Anastasia Rivkin
exaly   +3 more sources

Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis

American Journal of Obstetrics and Gynecology, 2006
Efficacy study of suppressive vaginal metronidazole in reducing recurrent symptomatic episodes of bacterial vaginosis.Multicenter prospective study with initial 10-day open-label metronidazole gel in which asymptomatic responders randomly assigned to receive twice weekly metronidazole vaginal gel or placebo for 16 weeks and off therapy for 12 weeks.Of ...
Paul Nyirjesy, Jack Sobel, Jeffrey Peipert   +2 more
exaly   +3 more sources

Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis

Microbes and Infection, 2006
Bacterial vaginosis (BV) is particularly common in black women, and in Nigeria it is often caused by Mycoplasma, as well as Atopobium, Prevotella and Gardnerella sp. Antimicrobial metronidazole oral therapy is poorly effective in eradicating the condition and restoring the Lactobacillus microbiota in the vagina.
Gregor Reid, Kingsley C Anukam, Andrew W Bruce   +2 more
exaly   +3 more sources

Formulation design and evaluation of metronidazole microspheres in a bioadhesive gel for local therapy of vaginal candidiasis [PDF]

, 2011
The purpose of this study was to design a novel vaginal delivery system composed of metronidazole microspheres dispersed within a bioadhesive gel. Microspheres were prepared by solvent evaporation method using Eudragit RS-100 and RL-100 polymers with different drug/polymer ratios.
Hani, Umme, Bhat, Sudeendra R., Shivakumar, Hosakote G.   +2 more
openaire   +3 more sources

Electrospun metronidazole-loaded nanofibers for vaginal drug delivery

Drug Development and Industrial Pharmacy, 2020
Objective: To develop and characterize innovative vaginal dosage forms for the treatment of bacterial vaginosis (BV). Significance: This study is the first comparative evaluation of the metronidazole (MET)-loaded polyvinylpyrrolidone (PVP) nanofiber ...
Sinem Saar, Fusun Acartürk, Fatma Nur Tuğcu Demiröz   +2 more
exaly   +2 more sources

FORMULATION AND DEVELOPMENT OF LONG-ACTING THERMOSENSITIVE AND MUCOADHESIVE VAGINAL GEL OF METRONIDAZOLE

INDIAN DRUGS, 2023
The development of an in situ metronidazole gel that is mucoadhesive and thermo sensitive was the aim of this study in the fight against bacterial vaginosis. Numerous evaluation criteria have been carried out, including mucoadhesive force, pH, viscosity, syringe capability, medication content, gelation temperature, and gelation time.
Azima G. Munshi, Manish Goyani, Meghraj V. Suryawanshi   +2 more
openaire   +1 more source

Metronidazole for Bacterial Vaginosis: A Comparison of Vaginal Gel vs. Oral Therapy

Obstetric and Gynecologic Survey, 2001
To compare the efficacy and safety of 0.75% metronidazole vaginal gel with oral metronidazole for the treatment of bacterial vaginosis (BV).Nonpregnant women with BV were enrolled in a multicenter, randomized, investigator-blind treatment trial. Patients were randomly assigned to either 0.75% metronidazole vaginal gel (5 g twice daily for five days) or
J M, Hanson, J A, McGregor, S L, Hillier, D A, Eschenbach, A K, Kreutner, R P, Galask, M, Martens   +6 more
openaire   +2 more sources